GovWire

Research: ACMD review of the evidence on the use and harms of diphenidine

Advisory Council On The Misuse Of Drugs

May 26
12:03 2023

ACMD review of the evidence on the use and harms of diphenidine

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Letter from ACMD to the Home Secretary: ACMD review of diphenidine

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

In 2022 the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to give advice on the appropriate classification and scheduling of diphenidine under the Misuse of Drugs Act 1971. Diphenidine was added to schedule II of the Convention on Psychotropic Substances of 1971 during the 64th Commission on Narcotic Drugs (CND) meeting in April 2021.

The ACMD has written this report describing the use and harms of diphenidine and related substances ephenidine, methoxyphenidine, fluorolintane and isophenidine. The report provides recommendations of their classification and scheduling, following a thorough review of the evidence available.

We are aware this publication may have accessibility issues. We are reviewing it so that we can fix these. Read more about our accessible documents policy.

Published 25 May 2023
Last updated 26 May 2023

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: